Condition | Indicated | Relationship Strength | Studies | Trials |
Adenocarcinoma Of Kidney [description not available] | 0 | 2.57 | 2 | 0 |
Cancer of Kidney [description not available] | 0 | 2.57 | 2 | 0 |
Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. | 0 | 2.57 | 2 | 0 |
Kidney Neoplasms Tumors or cancers of the KIDNEY. | 0 | 2.57 | 2 | 0 |
Bone Cancer [description not available] | 0 | 2.21 | 1 | 0 |
Osteogenic Sarcoma [description not available] | 0 | 2.21 | 1 | 0 |
Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. | 0 | 2.21 | 1 | 0 |
Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) | 0 | 7.21 | 1 | 0 |
Cancer of Pancreas [description not available] | 0 | 2.1 | 1 | 0 |
Invasiveness, Neoplasm [description not available] | 0 | 2.1 | 1 | 0 |
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). | 0 | 2.1 | 1 | 0 |